XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at the beginning of the period (in shares) at Dec. 31, 2020 25,402        
Balance at the beginning of the period at Dec. 31, 2020 $ 243,854        
Balance at the end of the period (in shares) at Mar. 31, 2021 25,402        
Balance at the end of the period at Mar. 31, 2021 $ 243,854        
Balance at the beginning of the period (in shares) at Dec. 31, 2020   4,713      
Balance at the beginning of the period at Dec. 31, 2020 (182,894) $ 0 $ 18,788 $ (14) $ (201,668)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance upon exercise of options (in shares)   504      
Issuance upon exercise of options 1,225   1,225    
Stock-based compensation expense 650   650    
Unrealized gain on cash equivalents (16)     (16)  
Net loss (12,822)       (12,822)
Balance at the end of the period (in shares) at Mar. 31, 2021   5,217      
Balance at the end of the period at Mar. 31, 2021 $ (193,857) $ 0 20,663 (30) (214,490)
Balance at the beginning of the period (in shares) at Dec. 31, 2020 25,402        
Balance at the beginning of the period at Dec. 31, 2020 $ 243,854        
Balance at the end of the period (in shares) at Jun. 30, 2021 29,850        
Balance at the end of the period at Jun. 30, 2021 $ 328,564        
Balance at the beginning of the period (in shares) at Dec. 31, 2020   4,713      
Balance at the beginning of the period at Dec. 31, 2020 (182,894) $ 0 18,788 (14) (201,668)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (27,402)        
Balance at the end of the period (in shares) at Jun. 30, 2021   5,792      
Balance at the end of the period at Jun. 30, 2021 $ (206,306) $ 0 22,803 (39) (229,070)
Balance at the beginning of the period (in shares) at Mar. 31, 2021 25,402        
Balance at the beginning of the period at Mar. 31, 2021 $ 243,854        
Redeemable Convertible Preferred Stock          
Issuance of preferred stock, net of issuance costs (in shares) 4,448        
Issuance of preferred stock, net of issuance costs $ 84,710        
Balance at the end of the period (in shares) at Jun. 30, 2021 29,850        
Balance at the end of the period at Jun. 30, 2021 $ 328,564        
Balance at the beginning of the period (in shares) at Mar. 31, 2021   5,217      
Balance at the beginning of the period at Mar. 31, 2021 (193,857) $ 0 20,663 (30) (214,490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance upon exercise of options (in shares)   575      
Issuance upon exercise of options 1,415   1,415    
Stock-based compensation expense 725   725    
Unrealized gain on cash equivalents (9)     (9)  
Net loss (14,580)       (14,580)
Balance at the end of the period (in shares) at Jun. 30, 2021   5,792      
Balance at the end of the period at Jun. 30, 2021 $ (206,306) $ 0 22,803 (39) (229,070)
Balance at the beginning of the period (in shares) at Dec. 31, 2021 0        
Balance at the beginning of the period at Dec. 31, 2021 $ 0        
Balance at the end of the period (in shares) at Mar. 31, 2022 0        
Balance at the end of the period at Mar. 31, 2022 $ 0        
Balance at the beginning of the period (in shares) at Dec. 31, 2021   43,676      
Balance at the beginning of the period at Dec. 31, 2021 267,091 $ 0 528,666 (54) (261,521)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance upon exercise of options (in shares)   401      
Issuance upon exercise of options 1,291   1,291    
Stock-based compensation expense 1,552   1,552    
Unrealized gain on cash equivalents 1     1  
Net loss (17,185)       (17,185)
Balance at the end of the period (in shares) at Mar. 31, 2022   44,077      
Balance at the end of the period at Mar. 31, 2022 $ 252,750 $ 0 531,509 (53) (278,706)
Balance at the beginning of the period (in shares) at Dec. 31, 2021 0        
Balance at the beginning of the period at Dec. 31, 2021 $ 0        
Balance at the end of the period (in shares) at Jun. 30, 2022 0        
Balance at the end of the period at Jun. 30, 2022 $ 0        
Balance at the beginning of the period (in shares) at Dec. 31, 2021   43,676      
Balance at the beginning of the period at Dec. 31, 2021 267,091 $ 0 528,666 (54) (261,521)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (36,369)        
Balance at the end of the period (in shares) at Jun. 30, 2022   44,538      
Balance at the end of the period at Jun. 30, 2022 $ 239,188 $ 0 537,046 32 (297,890)
Balance at the beginning of the period (in shares) at Mar. 31, 2022 0        
Balance at the beginning of the period at Mar. 31, 2022 $ 0        
Balance at the end of the period (in shares) at Jun. 30, 2022 0        
Balance at the end of the period at Jun. 30, 2022 $ 0        
Balance at the beginning of the period (in shares) at Mar. 31, 2022   44,077      
Balance at the beginning of the period at Mar. 31, 2022 252,750 $ 0 531,509 (53) (278,706)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance upon exercise of options (in shares)   400      
Issuance upon exercise of options 1,572   1,572    
Shares issued under employee stock purchase plan (in shares)   61      
Shares issued under employee stock purchase plan 1,289   1,289    
Stock-based compensation expense 2,676   2,676    
Unrealized gain on cash equivalents 85     85  
Net loss (19,184)       (19,184)
Balance at the end of the period (in shares) at Jun. 30, 2022   44,538      
Balance at the end of the period at Jun. 30, 2022 $ 239,188 $ 0 $ 537,046 $ 32 $ (297,890)